Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan

Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptor

(2012) Amélie Dufaÿ Wojcicki et al.   JOURNAL OF CONTROLLED RELEASE

Development of 5-Fluorouracil Derivatives as Anticancer Agents

(2011) Xiaoyan Pan et al.   CURRENT MEDICINAL CHEMISTRY

Hyaluronan-CD44 interactions as potential targets for cancer therapy

(2011) Suniti Misra et al.   FEBS Journal

Synthesis and controlled release of mitomycin C from a chitosan-based polymeric prodrug

(2011) Lihong Duan et al.   JOURNAL OF CONTROLLED RELEASE

Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism

(2011) Chad E. Galer et al.   ORAL ONCOLOGY

UFT (tegafur-uracil) in rectal cancer

(2008) E. Casado et al.   ANNALS OF ONCOLOGY

In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer–5-fluorouracil conjugates

(2008) Fang Yuan et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor

(2008) Virginia M. Platt et al.   MOLECULAR PHARMACEUTICS

Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review

(2008) Georgios Koukourakis et al.   MOLECULES